What is it about?

In this study, weighted gene co-expression network analysis (WGCNA) has been used to identify differentially expressed genes in CIS disease and the main pathways associated with it.

Featured Image

Why is it important?

The new disease-involved pathways may be considered potential therapeutic goals for CIS management in the future.

Read the Original

This page is a summary of: Riboflavin and Histidine Metabolisms Are Two Key Pathways Related to the Clinically Isolated Syndrome (CIS): A WGCNA-based In silico Analysis, Current Pharmacogenomics and Personalized Medicine, April 2023, Bentham Science Publishers,
DOI: 10.2174/1875692120666230504114225.
You can read the full text:



The following have contributed to this page